Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
29.44
-1.71 (-5.49%)
At close: Jun 26, 2026, 4:00 PM EDT
30.02
+0.58 (1.97%)
After-hours: Jun 26, 2026, 6:54 PM EDT
Aktis Oncology Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Aktis Oncology stock have an average target of 34, with a low estimate of 30 and a high estimate of 40. The average target predicts an increase of 15.49% from the current stock price of 29.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aktis Oncology stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +35.87% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +18.89% | Jun 2, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +15.49% | Jun 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
Financial Forecast
Revenue This Year
10.58M
from 6.50M
Increased by 62.78%
Revenue Next Year
11.55M
from 10.58M
Increased by 9.21%
EPS This Year
-1.60
from -78.34
EPS Next Year
-1.94
from -1.60
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.8M | 35.0M | |
| Avg | 10.6M | 11.6M | |
| Low | 3.2M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 235.5% | 230.9% | |
| Avg | 62.8% | 9.2% | |
| Low | -50.3% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.12 | -1.41 | |
| Avg | -1.60 | -1.94 | |
| Low | -2.08 | -3.07 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.